Conversely, GBM patients with low CD8+ T cell abundance and low ITGAE expression (Figure 7A, group 1) had lower cumulative survival when compared to those patients with high CD8+ T cell abundance and low ITGAE gene expression (Figure 7A, group 2). This evidence concerns the gene CD8A and glioblastoma.